Journal of Clinical PracticeJournal of Clinical PracticeКлиническая практика2220-30952618-8627Eco-Vector830810.17816/clinpract5435-40ArticlesСтатьиResearch ArticleREVASCULARISATION IN SUDDEN CARDIAC DEATH RISK REDUCTIONРОЛЬ РЕВАСКУЛЯРИЗАЦИИ МИОКАРДА В СНИЖЕНИИ РИСКА ВНЕЗАПНОЙ СЕРДЕЧНОЙ СМЕРТИYashinS MЯшинСергей Михайлович

заведующий кафедрой с клиникой госпитальной хирургии №2 ГБОУ ВПО ПСПбГМУ, им. акад. И.П. Павлова, д.м.н., профессор

smyashin@mail.ruGromykoG AГромыкоГригорий Алексеевич

врач сердечно5сосудистый хирург отделения хирургических методов диагностики и лечения тахиаритмий ФГКУ МО ГВКГ им. Н.Н. Бурденко, к.м.н.

gromyko2010@list.ruГБОУ ВПО ПСПбГМУФГКУ МО ГВКГ им. Н.Н. Бурденко1512201454NO4 (2014)№4 (2014)354016032018Copyright ©; 2014, Yashin S.M., Gromyko G.A.Copyright ©; 2014, Яшин С.М., Громыко Г.А.2014Yashin S.M., Gromyko G.A.Яшин С.М., Громыко Г.А.https://creativecommons.org/licenses/by-nc-nd/4.0https://clinpractice.ru/clinpractice/article/view/8308

This issue is about risk stratification and ability of risk reduction in patients undergoing revascularization procedures. Appropriate use of implantable cardioverter-defibrillator in this patients is also discussed.

В статье отражены современные взгляды на стратификацию риска и влияние реваскуляризации на прогноз у больных с ишемической болезнью сердца. Обсуждаются особенности применения имплантируемых кардиовертеров-дефибрилляторов в данной группе пациентов.

sudden cardiac deathImplantable cardioverter"defibrillatorcoronary artery diseaserevascularisationвнезапная сердечная смертьимплантируемый кардиовертер " дефибрилляторишемическая болезнь сердцареваскуляризация миокардаMyerburg R.J. Sudden cardiac death: exploring the limits of our knowledge. J Cardiovasc Electrophysiol 2001;12:369-81.Fox C.S., Evans J.C., M.G. ,Larson M.G. et al. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950-1999: the Framingham Heart Study. Circulation 2004;110: 522-27.Huikuri, H., Castellanos A., Myerburg R.J. Sudden death due to cardiac arrhythmias. New England J Med 2001;345:1473-82.Myerburg R.J., Kessler K.M., Mallon S.M. et al. Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary artery spasm. New England J Med 1992;326: 1451-55.Furukawa T., Bassett A.L., Furukawa N. et al. The ionic mechanism of reperfusion-induced early after depolarizations in the feline left ventricular hypertrophy. J Clin Invest. 1993;91:1521-31.Goldberg R.J., Yarzebski J., Spencer F.A. et al. Thirty-year trends (1975-2005) in the magnitude, patient characteristics, and hospital outcomes of patients with acute myocardial infarction com"plicated by ventricular fibrillation. Am J Cardiol. 2008;102:1595-1601.Myerburg R.J., Juhani Junttila M. Sudden Cardiac Death Caused by Coronary Heart Disease. Circulation 2012;125:1043-52.Alderman E.L., Bourassa M.G., Cohen L.S. et al. Ten year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation 1990;82:1629-46.The VA Cooperative Study Group. Eighteen-year follow-up in the Veterans Affairs Cooperative Study of coronary artery by-pass surgery for stable angina. Circulation 1992;86:121-30.Brugada J. Aguinaga L., Mont L,. et al. / Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome. J Am Coll Cardiol. 2001;37:529-33.Bigger J.T. Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. New England J Med 1997;337:1569-75.Bigger J.T. Jr., Whang W., Rottman J.N. et al. Mechanisms of Death in the CABG Patch Trial: A Randomized Trial of Implantable Cardiac Defibrillator Prophylaxis in Patients at High Risk of Death After Coronary Artery Bypass Graft Surgery. Circulation 1999;99:1416-21.Goldenberg I., Moss A, McNitt S., et al. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 2006;47:1811-181.Veenhuyzen, G.D., Singh S.N., D. McAreavey D. et al. Prior Coronary Artery Bypass Surgery and Risk of Death Among Patients With Ischemic Left Ventricular Dysfunction. Circulation 2001;104:1489-93.Wijns W., Kolh P., Danchin N. et al. Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Euro Heart Journal 2010;31:2501-55.Shahian D.M., O'Brien S.M., S. Sheng S., et al. Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). Circulation 2012;125:1491-1500.Weintraub W.S., Grau-Sepulveda M.V., Weiss J.M. et al. Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry. Circulation 2012;125:1501-10.Zishiri E. T., Williams S., Cronin E.M., et al. Early Risk of Mortality After Coronary Artery Revascularization in Patients With Left Ventricular Dysfunction and Potential Role of the Wearable Cardioverter Defibrillator. Circ Arrhythm Electrophysiol. 2013;6(1):117-28.